Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Congress. "Improving Regulatory Transparency for New Medical Therapies Act". Government. U.S. Government Publishing Office, November 25, 2015. https://www.govinfo.gov/app/details/COMPS-11760
Congress. (2015, November 25). Improving Regulatory Transparency for New Medical Therapies Act. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/COMPS-11760
Congress. Improving Regulatory Transparency for New Medical Therapies Act. U.S. Government Publishing Office, (25 Nov 2015), https://www.govinfo.gov/app/details/COMPS-11760
Congress, To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing., GovInfo, (November 25, 2015), https://www.govinfo.gov/app/details/COMPS-11760